Analysis: A tale of three pharma companies and a quarter

Cipla beat expectations riding the demand for Covid medication. The Street is likely to push the stock to its record high hit in 2015. While US business revenues declined, the company's domestic business sales grew in double-digits.

Disclaimer : Mytimesnow (MTN) lets you explore worldwide viral news just by analyzing social media trends. Tap read more at source for full news. The inclusion of any links does not necessarily imply any endorsement of the views expressed within them.